This story has been updated from a previous version.

NEW YORK, July 18 - With its sights set on joining the ranks of big pharma--at least in the field of oncology--Exelixis said Wednesday that it had signed a far-reaching deal with Bristol-Myers Squibb to jointly discover potential drug targets for cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.